Literature DB >> 31120258

Combining Hyperpolarized Real-Time Metabolic Imaging and NMR Spectroscopy To Identify Metabolic Biomarkers in Pancreatic Cancer.

Prasanta Dutta, Mayrim R Perez, Jaehyuk Lee, Yaan Kang, Michael Pratt, Travis C Salzillo, Joseph Weygand, Niki M Zacharias, Seth T Gammon, Eugene J Koay, Michael Kim, Florencia McAllister, Subrata Sen, Anirban Maitra, David Piwnica-Worms, Jason B Fleming1, Pratip K Bhattacharya.   

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is a deadly cancer that progresses without any symptom, and oftentimes, it is detected at an advanced stage. The lack of prior symptoms and effective treatments have created a knowledge gap in the management of this lethal disease. This issue can be addressed by developing novel noninvasive imaging-based biomarkers in PDAC. We explored in vivo hyperpolarized (HP) 13C MRS of pyruvate to lactate conversion and ex vivo 1H NMR spectroscopy in a panel of well-annotated patient-derived PDAC xenograft (PDXs) model and investigated the correlation between aberrant glycolytic metabolism and aggressiveness of the tumor. Real-time metabolic imaging data demonstrate the immediate intracellular conversion of HP 13C pyruvate to lactate after intravenous injection interrogating upregulated lactate dehydrogenase (LDH) activity in aggressive PDXs. Total ex vivo lactate measurement by 1H NMR spectroscopy showed a direct correlation with in vivo dynamic pyruvate-to-lactate conversion and demonstrated the potential of dynamic metabolic flux as a biomarker of total lactate concentration and aggressiveness of the tumor. Furthermore, the metabolite concentrations were very distinct among all four tumor types analyzed in this study. Overexpression of LDH-A and hypoxia-inducible factor (HIF-1α) plays a significant role in the conversion kinetics of HP pyruvate-to-lactate in tumors. Collectively, these data identified aberrant metabolic characteristics of pancreatic cancer PDXs and could potentially delineate metabolic targets for therapeutic intervention. Metabolic imaging with HP pyruvate and NMR metabolomics may enable identification and classification of aggressive subtypes of patient-derived xenografts. Translation of this real-time metabolic technique to the clinic may have the potential to improve the management of patients at high risk of developing pancreatic diseases.

Entities:  

Keywords:  NMR metabolomics; NMR spectroscopy patient derived xenograft (PDX); hyperpolarized metabolic imaging; pancreatic cancer; tumor metabolism

Year:  2019        PMID: 31120258     DOI: 10.1021/acs.jproteome.9b00132

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  11 in total

1.  Simple Esterification of [1-13C]-Alpha-Ketoglutarate Enhances Membrane Permeability and Allows for Noninvasive Tracing of Glutamate and Glutamine Production.

Authors:  Jenna E AbuSalim; Kazutoshi Yamamoto; Natsuko Miura; Burchelle Blackman; Jeffrey R Brender; Chandrasekhar Mushti; Tomohiro Seki; Kevin A Camphausen; Rolf E Swenson; Murali C Krishna; Aparna H Kesarwala
Journal:  ACS Chem Biol       Date:  2021-09-23       Impact factor: 4.634

2.  Metabolic Imaging Using Hyperpolarization for Assessment of Premalignancy.

Authors:  Shivanand Pudakalakatti; Priyank Raj; Travis C Salzillo; José S Enriquez; Dontrey Bourgeois; Prasanta Dutta; Mark Titus; Shayan Shams; Priya Bhosale; Michael Kim; Florencia McAllister; Pratip K Bhattacharya
Journal:  Methods Mol Biol       Date:  2022

Review 3.  Patient-Derived Xenograft Models of Pancreatic Cancer: Overview and Comparison with Other Types of Models.

Authors:  Patrick L Garcia; Aubrey L Miller; Karina J Yoon
Journal:  Cancers (Basel)       Date:  2020-05-22       Impact factor: 6.639

4.  Measuring the Metabolic Evolution of Glioblastoma throughout Tumor Development, Regression, and Recurrence with Hyperpolarized Magnetic Resonance.

Authors:  Travis C Salzillo; Vimbai Mawoneke; Joseph Weygand; Akaanksh Shetty; Joy Gumin; Niki M Zacharias; Seth T Gammon; David Piwnica-Worms; Gregory N Fuller; Christopher J Logothetis; Frederick F Lang; Pratip K Bhattacharya
Journal:  Cells       Date:  2021-10-01       Impact factor: 6.600

5.  Identifying the Metabolic Signatures of PPARD-Overexpressing Gastric Tumors.

Authors:  Shivanand Pudakalakatti; Mark Titus; José S Enriquez; Sumankalai Ramachandran; Niki M Zacharias; Imad Shureiqi; Yi Liu; James C Yao; Xiangsheng Zuo; Pratip K Bhattacharya
Journal:  Int J Mol Sci       Date:  2022-01-31       Impact factor: 6.208

6.  Identifying a novel IRF3/circUHRF1/miR-1306-5p/ARL4C axis in pancreatic ductal adenocarcinoma progression.

Authors:  Wei Liu; Lisha Deng; Anchun Xu; Xingcheng Xiong; Jing Tao; Jian Chang; Yiling Xu; Zhilin Zhou
Journal:  Cell Cycle       Date:  2022-01-05       Impact factor: 4.534

Review 7.  Hyperpolarized Magnetic Resonance and Artificial Intelligence: Frontiers of Imaging in Pancreatic Cancer.

Authors:  José S Enriquez; Yan Chu; Shivanand Pudakalakatti; Kang Lin Hsieh; Duncan Salmon; Prasanta Dutta; Niki Zacharias Millward; Eugene Lurie; Steven Millward; Florencia McAllister; Anirban Maitra; Subrata Sen; Ann Killary; Jian Zhang; Xiaoqian Jiang; Pratip K Bhattacharya; Shayan Shams
Journal:  JMIR Med Inform       Date:  2021-06-17

8.  Therapeutic efficacy of liposomal Grb2 antisense oligodeoxynucleotide (L-Grb2) in preclinical models of ovarian and uterine cancer.

Authors:  Olivia D Lara; Emine Bayraktar; Paola Amero; Shaolin Ma; Cristina Ivan; Wei Hu; Ying Wang; Lingegowda S Mangala; Prasanta Dutta; Pratip Bhattacharya; Ana Tari Ashizawa; Gabriel Lopez-Berestein; Cristian Rodriguez-Aguayo; Anil K Sood
Journal:  Oncotarget       Date:  2020-07-21

9.  hsa_circ_001653 Implicates in the Development of Pancreatic Ductal Adenocarcinoma by Regulating MicroRNA-377-Mediated HOXC6 Axis.

Authors:  Huijuan Shi; Hui Li; Tiantian Zhen; Yu Dong; Xiaojuan Pei; Xiangliang Zhang
Journal:  Mol Ther Nucleic Acids       Date:  2020-01-10       Impact factor: 8.886

10.  Early Detection of Pancreatic Intraepithelial Neoplasias (PanINs) in Transgenic Mouse Model by Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy.

Authors:  Prasanta Dutta; Susana Castro Pando; Marilina Mascaro; Erick Riquelme; Michelle Zoltan; Niki M Zacharias; Seth T Gammon; David Piwnica-Worms; Mark D Pagel; Subrata Sen; Anirban Maitra; Shayan Shams; Florencia McAllister; Pratip K Bhattacharya
Journal:  Int J Mol Sci       Date:  2020-05-25       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.